08513.HK
MaxWin International Holdings Limited
HKSE · Healthcare · Medical - Equipment & Services · SG
HKD 0.37
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 22.6M | 18.6M | 10.5M | 9.1M | 13.9M |
| Cost of Revenue | 19.4M | 15.5M | 10.4M | 9.9M | 13.7M |
| Gross Profit | 3.1M | 3.1M | 44.0K | (730.0K) | 938.0K |
| Operating Expenses | |||||
| R&D Expense | 139.0K | 403.0K | 559.0K | 1.6M | 291.0K |
| SG&A Expense | 3.0M | 3.1M | 2.8M | 2.9M | 2.5M |
| General & Admin Expense | 2.8M | 3.0M | 2.5M | 2.5M | 3.2M |
| Selling & Marketing Expense | 171.0K | 174.0K | 301.0K | 383.0K | 382.0K |
| Other Expenses | 96.0K | (152.0K) | (684.0K) | 968.0K | (479.0K) |
| Total Operating Expenses | 3.2M | 3.4M | 2.7M | 3.9M | 2.3M |
| Cost and Expenses | 22.6M | 18.9M | 13.1M | 13.7M | 16.1M |
| Operating Income (EBIT) | (69.0K) | (322.0K) | (2.6M) | (4.6M) | (2.2M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 213.8K | 274.0K | 167.0K | 159.0K | 124.0K |
| Net Interest Income | (394.8K) | (274.0K) | (167.0K) | (159.0K) | (124.0K) |
| Other Non-Op Income/Expense | (288.0K) | (278.0K) | (167.0K) | (159.0K) | (124.0K) |
| Non-Operating Income (excl Interest) | (587.0K) | — | (634.0K) | — | 87.0K |
| EBT (Pre-Tax Income) | (357.0K) | (600.0K) | (2.8M) | (4.8M) | (2.3M) |
| Income Tax Expense | 49.0K | 12.0K | (154.0K) | (74.0K) | 98.0K |
| Bottom Line | |||||
| Net Income | (406.0K) | (612.0K) | (2.6M) | (6.7M) | (3.1M) |
| Earnings from Cont. Ops | (406.0K) | (612.0K) | (2.6M) | (4.7M) | (2.4M) |
| Earnings from Discont. Ops | — | — | — | (2.2M) | (684.0K) |
| Bottom Line Net Income | (406.0K) | (612.0K) | (2.6M) | (4.6M) | (2.9M) |
| Per Share | |||||
| Basic EPS | (HK$0.00) | (HK$0.01) | (HK$0.04) | (HK$0.08) | (HK$0.06) |
| Diluted EPS | (HK$0.01) | (HK$0.01) | (HK$0.04) | (HK$0.12) | (HK$0.06) |
| Revenue Per Share | HK$0.32 | HK$0.23 | HK$0.14 | HK$0.16 | HK$0.26 |
| Shares | |||||
| Basic Shares Outstanding | 70.0M | 81.8M | 74.0M | 56.8M | 52.7M |
| Diluted Shares Outstanding | 70.0M | 81.8M | 74.0M | 57.1M | 52.7M |
| Profitability Metrics | |||||
| EBITDA | 717.8K | 598.0K | (1.3M) | (2.4M) | (1.8M) |
| D&A | 199.8K | 333.0K | 636.0K | 2.2M | 479.0K |
| EBIT | 518.0K | (160.7K) | (2.0M) | (4.6M) | (2.2M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026